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Letters to the EditorReply to the Editor:
We appreciate the comments of Bottio
and colleagues on our recent report of
intraoperative failure involving 4 bovine
pericardial mitral prostheses.1 The corre-
spondents point out that Carpentier-Ed-
wards Perimount bioprostheses require
physiologic pressure to overcome the in-
herent limited leaflet coaptation that re-
sults from no-pressure fixation. They fur-
ther comment that had the valves in our
report been subjected to more physio-
logic hemodynamics, they might have
demonstrated normal function.
To correct any misunderstanding, we
would note that 2 of the valve failures were
demonstrated after separating from cardio-
pulmonary bypass with acceptable hemo-
dynamics. At physiologic pressures, there
was still massive incompetence, as demon-
strated by means of transesophageal echo-
cardiography. The other 2 failed valves
were tested before atrial closure. In each of
these cases, the degree of insufficiency ob-
served by the surgeons was extremely se-
vere and far greater than that associated
with incomplete closure of a pericardial
valve at low pressures, a phenomenon with
which we are quite familiar.
Paul C. Saunders, MD
Eugene Grossi, MD
Department of Surgery
New York University Medical Center
New York, NY 10016
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Letter to the Editor
Moderate mitral regurgitation repair
at the time of coronary bypass:
When is it required?
To the Editor:
We read with great interest the article
recently published in the Journal by Mal-
lidi and colleagues1 concerning the de-
bated dilemma of whether to treat mild-
to-moderate mitral regurgitation (MR) at
the time of coronary artery bypass graft-
ing (CABG).
The authors studied a consecutive series
of 163 patients with mild-to-moderate MR
796 The Journal of Thoracic and Cardiovaundergoing isolated CABG matched 1:2 with
326 patients without MR undergoing the
same operation. Several preoperative vari-
ables were considered for matching. Among
them, the extent of coronary disease, left ven-
tricular (LV) ejection fraction, functional
New York Heart Association class, and re-
cent myocardial infarction were the specific
variables. The authors report that patients
with MR had poor event-free survival and
worse late functional status at follow-up.
They conclude that “consideration should be
given to repairing moderate MR to improve
long-term quality of life.”
This is a very interesting topic, about
which there is conflicting evidence in the
literature. The importance of the cardiac
variables chosen by the authors for
matching the 2 groups of patients is out
of discussion, but in our opinion the in-
creasing attention on LV volume as a
prognostic indicator after infarction and
CABG should be taken into consider-
ation. LV volume is often unreported in
articles concerning CABG in ischemic
cardiomyopathy, even if it seems now
clear that LV enlargement is far more
predictive of postoperative outcome2,3
and determines the ultimate prognosis.4,5
Yet it cannot be ignored that there is not
necessarily correspondence between low
EF and LV volumes. The authors report
that 44.5% of patients had poor preoper-
ative LV function (40%); at late fol-
low-up, 20% of patients in the MR group
were in New York Heart Association
functional class III/IV; and in a subset of
49 patients with echocardiographic late
evaluation, one third had worsening of
the MR. It would be very interesting to
know the preoperative, as well as the late,
LV volume in all of these subgroups of
patients. Probably a subgroup requiring
mitral valve repair would be recognized.
We fully agree with Mallidi and col-
leagues1 that at the time of CABG, the
“finding of mild to moderate MR should
not be treated as an incidental finding but
should be further evaluated.” We also
support that an accurate and complete
evaluation is mandatory, but one point
should be kept in mind: more important
than MR grade itself is the LV morpho-
functional status, which should guide the
surgical indications and the choice of the
best treatment. As Steven Bolling is
wont to say: “ischemic mitral regurgita-
scular Surgery ● November 2004tion is a ventricular disease, not a valvu-
lar disease.”
Pino Fundarò, MD
Paolo Tartara, MD
Ettore Vitali, MD
Ospedale Niguarda Ca’Granda
Dipartimento Cardiotoracovascolare A. De
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Unità Operativa di Cardiochirurgia
Milan, Italy
References
1. Mallidi HR, Pelletier MP, Lamb J, Desai N,
Sever J, Christakis GT, et al. Late outcomes
in patients with uncorrected mild to moderate
mitral regurgitation at the time of isolated
coronary artery bypass grafting. J Thorac
Cardiovasc Surg. 2004;127:636-44.
2. Yamaguchi A, Ino T, Adachi H, Murata S,
Kamio H, Okada M, et al. Left ventricular
volume predicts postoperative course in pa-
tients with ischemic cardiomyopathy. Ann
Thorac Surg. 1998;65:434-8.
3. Maxey TS, Reece TB, Ellman PI, Butler PD,
Kern JA, Tribble CG, et al. Coronary artery
bypass with ventricular restoration is superior
to coronary artery bypass alone in patients
with ischemic cardiomyopathy. J Thorac
Cardiovasc Surg. 2004;127:428-34.
4. Buckberg GD. Congestive heart failure: treat
the disease, not the symptoms—return to nor-
malcy. J Thorac Cardiovasc Surg. 2001;121:
628-37.
5. Schinkel AFL, Poldermans D, Rizzello V,
Vanoverschelde J-LJ, Elhendy A, Boersma E,
et al. Why do patients with ischemic cardiomy-
opathy and a substantial amount of viable myo-
cardium not always recover in function after
revascularization? J Thorac Cardiovasc Surg.
2004;127:385-90.
doi:10.1016/j.jtcvs.2004.05.032
Reply to the Editor:
We agree with Drs Fundarò, Tartara, and
Vitali that ischemic mitral regurgitation
(MR) is a disease process with many un-
answered questions regarding its ideal
treatment. The purpose of our study was to
determine the clinical outcomes of patients
treated with isolated coronary artery bypass
grafting who also had mild-to-moderate
MR on a preoperative ventriculogram.1
When compared with a similar cohort with-
out preoperative MR, our data revealed
similar late survival but worse event-free
survival and late functional status for those
patients with preoperative MR. In those
patients with both preoperative and postop-
erative echocardiograms, approximately
one third demonstrated worsening MR.
However, ventriculography alone is inade-
quate to properly assess MR preopera-
